Compare IDXX & CVNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | CVNA |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.1B | 45.0B |
| IPO Year | 1991 | 2017 |
| Metric | IDXX | CVNA |
|---|---|---|
| Price | $713.59 | $400.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 22 |
| Target Price | ★ $683.89 | $410.86 |
| AVG Volume (30 Days) | 593.8K | ★ 2.8M |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.65 | N/A |
| EPS | ★ 12.60 | 4.40 |
| Revenue | $4,167,411,000.00 | ★ $18,266,000,000.00 |
| Revenue This Year | $12.15 | $48.53 |
| Revenue Next Year | $8.79 | $27.15 |
| P/E Ratio | ★ $56.67 | $90.94 |
| Revenue Growth | 8.39 | ★ 45.55 |
| 52 Week Low | $356.14 | $148.25 |
| 52 Week High | $769.98 | $413.34 |
| Indicator | IDXX | CVNA |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 69.53 |
| Support Level | $722.29 | $308.50 |
| Resistance Level | $739.15 | $401.55 |
| Average True Range (ATR) | 21.85 | 18.17 |
| MACD | -3.27 | 9.15 |
| Stochastic Oscillator | 46.16 | 92.41 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.